Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Subcortical vascular dementia.

Timo Erkinjuntti1

  • 1Memory Research Unit, Department of Clinical Neurosciences, University of Helsinki, Finland. timo.erkinjuntti@huch.fi

Cerebrovascular Diseases (Basel, Switzerland)
|March 20, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurofilament light level correlates with brain atrophy, and cognitive and motor performance.

Frontiers in aging neuroscience·2023
Same author

Neuropsychiatric symptoms are associated with exacerbated cognitive impairment in covert cerebral small vessel disease.

Journal of the International Neuropsychological Society : JINS·2022
Same author

Post-Stroke Cognitive Impairment is Frequent After Infra-Tentorial Infarct.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2021
Same author

Synergistic associations of cognitive and motor impairments with functional outcome in covert cerebral small vessel disease.

European journal of neurology·2021
Same author

A novel CT-based automated analysis method provides comparable results with MRI in measuring brain atrophy and white matter lesions.

Neuroradiology·2021
Same author

Associations of cognitive reserve and psychological resilience with cognitive functioning in subjects with cerebral white matter hyperintensities.

European journal of neurology·2021
Same journal

JR-ZQSI-NICHE: A Digital Neurosurgical Decision Support System for Spontaneous Intracerebral Hemorrhage.

Cerebrovascular diseases (Basel, Switzerland)·2026
Same journal

Variations across Europe in national guidelines and clinical practice regarding screening of cognitive and emotional consequences after aneurysmal subarachnoid hemorrhage.

Cerebrovascular diseases (Basel, Switzerland)·2026
Same journal

Intravenous Thrombolysis Before Versus Direct Endovascular Treatment for Acute Ischemic Stroke Due to Large Vessel Occlusion: A Systematic Review and Meta-analysis.

Cerebrovascular diseases (Basel, Switzerland)·2026
Same journal

Erratum.

Cerebrovascular diseases (Basel, Switzerland)·2026
Same journal

Association between extubation timing and functional outcomes in patients with acute ischemic stroke after endovascular treatment.

Cerebrovascular diseases (Basel, Switzerland)·2026
Same journal

Achieving the 'golden hour': evaluating and optimising the spatial distribution of comprehensive stroke centers in Liaoning Province, China.

Cerebrovascular diseases (Basel, Switzerland)·2026
See all related articles

Subcortical vascular dementia (VaD), a subtype of VaD, offers a more homogeneous group for clinical trials. Focusing on this specific form of VaD may lead to more predictable outcomes and treatment responses.

Area of Science:

  • Neurology
  • Neuroscience
  • Vascular Medicine

Background:

  • Vascular dementia (VaD) encompasses diverse vascular mechanisms, brain changes, causes, and clinical presentations.
  • Current VaD diagnostic criteria result in etiological and clinical heterogeneity, impacting clinical trial efficacy.
  • This heterogeneity poses challenges for drug development and treatment strategies in VaD research.

Purpose of the Study:

  • To propose subcortical (ischaemic) VaD as a more homogeneous subgroup for clinical drug trials.
  • To define the specific characteristics of subcortical VaD for improved research focus.
  • To explore the potential for more predictable clinical outcomes and treatment responses within this subtype.

Main Methods:

  • Review and synthesis of existing literature on VaD subtypes and diagnostic criteria.

Related Experiment Videos

  • Identification of key pathological and clinical features distinguishing subcortical VaD.
  • Analysis of the implications of definitional homogeneity for clinical trial design.

    • Main Results:

    • Subcortical VaD is characterized by small vessel disease, lacunar infarcts, and white matter lesions in subcortical brain regions.
    • This subtype integrates 'Binswanger's disease' and 'the lacunar state' under a unified definition.
    • A homogeneous group is expected to yield more predictable clinical pictures and natural histories.

    Conclusions:

    • Focusing on subcortical VaD offers a viable strategy to address the heterogeneity challenge in VaD research.
    • This approach may enhance the predictability of clinical trial results and treatment responses.
    • Further research into subcortical VaD could refine diagnostic and therapeutic strategies for vascular dementia.